Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 8011 AL 8025

The Neuro-Healing Frontier: Alpha-Mangostin's Potential in Alzheimer's and Parkinson's Treatment

Goyal A, Agrawal N, Agrawal N, Verma A, Solanki K, Yadav HN.

Comb Chem High Throughput Screen. 2025;28(12):1989-1999. doi: 10.2174/0113862073311357240626103752.

Telemedicine in Alzheimer's disease and other dementias: Where we are?

Angelopoulou E, Papageorgiou SG.

J Alzheimers Dis. 2025 Jan;103(1):3-18. doi: 10.1177/13872877241298295. Epub 2024 Dec 5.

"Current and emerging drug therapies in Alzheimer's disease: A pathophysiological Perspective"

Aparajita A, Jain U, Srivastava P.

Neuroscience. 2025 Jan 26;565:499-518. doi: 10.1016/j.neuroscience.2024.11.078. Epub 2024 Dec 9.

Targeting tau in Alzheimer's and beyond: Insights into pathology and therapeutic strategies

Singh S, Khan S, Shahid M, Sardar M, Hassan MI, Islam A.

Ageing Res Rev. 2025 Feb;104:102639. doi: 10.1016/j.arr.2024.102639. Epub 2024 Dec 16.

Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis

Jiang M, Chi J, Qiao Y, Wang J, Zhang Z, Liu J, Sheng X, Yuan L.

Pharmacol Res. 2025 Feb;212:107578. doi: 10.1016/j.phrs.2025.107578. Epub 2025 Jan 3.

Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Ali AA, Abu-Alghayth MH.

Ageing Res Rev. 2025 Mar;105:102684. doi: 10.1016/j.arr.2025.102684. Epub 2025 Feb 4.

Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer's disease and Parkinson's disease: Therapeutic avenue of Dual OXR Antagonist (DORA)

Panda SP, Sinha S, Kesharwani A, Kumar S, Singh M, Kondepudi GM, Samuel A, Sanghi AK, Thapliyal S, Chaubey KK, Guru A.

Biochem Pharmacol. 2025 Mar;233:116794. doi: 10.1016/j.bcp.2025.116794. Epub 2025 Feb 5.

Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders

Almutary AG, Begum MY, Siddiqua A, Gupta S, Chauhan P, Wadhwa K, Singh G, Iqbal D, Padmapriya G, Kumar S, Kedia N, Verma R, Kumar R, Sinha A, Dheepak B, Abomughaid MM, Jha NK.

Mol Neurobiol. 2025 Jun;62(6):7975-7997. doi: 10.1007/s12035-024-04654-y. Epub 2025 Feb 17.

Current amyloid inhibitors: Therapeutic applications and nanomaterial-based innovations

López-García P, Tejero-Ojeda MM, Vaquero ME, Carrión-Vázquez M.

Prog Neurobiol. 2025 Apr;247:102734. doi: 10.1016/j.pneurobio.2025.102734. Epub 2025 Feb 28.

The role of semaphorin 3A in the pathogenesis and progression of Alzheimer's disease and other aging-related diseases: A comprehensive review

Yuan J, Huang R, Nao J, Dong X.

Pharmacol Res. 2025 May;215:107732. doi: 10.1016/j.phrs.2025.107732. Epub 2025 Apr 11.

RNA-Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins

Rabbani SA, El-Tanani M, Sharma S, El-Tanani Y, Kumar R, Saini M, Yadav M, Khan MA, Parvez S.

Eur J Neurosci. 2025 Apr;61(8):e70110. doi: 10.1111/ejn.70110.

Plant-Based Therapies to Ameliorate Neuroinflammation in Parkinson's Disease, Alzheimer's Disease, and Epilepsy: A Narrative Review

Sharma D, Rajbongshi B, Isphak T, Basumatary S, Dutta K, Rudrapal M, Goswami AK.

Chem Biodivers. 2025 Sep;22(9):e202500038. doi: 10.1002/cbdv.202500038. Epub 2025 May 20.

Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer's Disease and Parkinson's Disease

Jung YH, Jo HY, Kim DH, Oh YJ, Kim M, Na S, Song HY, Lee HJ.

Int J Nanomedicine. 2025 Apr 17;20:4903-4917. doi: 10.2147/IJN.S513816. eCollection 2025.

Longitudinal comparative analysis of antidepressants and anti-anxiety medications in Alzheimer's and Parkinson's diseases: insights from French and British health records

Hamieh N, Ansart M, Guinebretiere O, Lekens B, Gantzer L, Durrleman S, Nedelec T.

J Affect Disord. 2025 Aug 1;382:148-153. doi: 10.1016/j.jad.2025.04.094. Epub 2025 Apr 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias